Fayetteville, Arkansas Clinical Trials

A listing of Fayetteville, Arkansas clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 27 clinical trials
Brief Title: Study of Efficacy and Safety of Canakinumab as Adjuvant Therapy in Adult Subjects With Stages AJCC/UICC v. 8 II-IIIA and IIIB (T>5cm N2) Completely Resected Non-small Cell Lung Cancer Acronym: CANOPY-A

The primary purpose of the study is to compare the efficacy and safety of canakinumab versus placebo as adjuvant therapy in adult subjects with stages AJCC/UICC v. 8 II -IIIA and the subset of IIIB (T>5cm N2 disease) completely resected (R0) non-small cell lung cancer (NSCLC).

lung carcinoma
systemic therapy
Highlands Oncology Group
 (7.8 away) Contact site
  • 16 Sep, 2021
  • +416 other locations
NOWDx Test for the Detection of Antibodies to COVID-19 in Lay Persons

This study is designed to compare the performance of the NOWDx COVID-19 Test to an emergency use authorized PCR test result. The intent is to show the rapid test device is comparable to a currently marketed device. The NOWDx COVID-19 Test is an in vitro lateral flow immunoassay intended for …

Medical Arts Pharmacy
 (7.4 away) Contact site
  • 05 Sep, 2021
  • +5 other locations
A Study of U3-1402 in Subjects With Metastatic Breast Cancer

This study is to evaluate safety and efficacy of an antibody drug conjugate U3-1402 in patients with metastatic breast cancer (MBC) who have received no prior anti-HER2 therapy.

Highlands Oncology Group
 (6.3 away) Contact site
  • 15 Sep, 2021
  • +8 other locations
Pepinemab in Combination With Pembrolizumab in Advanced Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

The purpose of the study is to evaluate the safety and tolerability of pepinemab in combination with pembrolizumab and determine a recommended Phase 2 dose (RP2D) in patients with advanced, recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC).

Highlands Oncology Group, PA - North Hills
 (6.3 away) Contact site
  • 15 Sep, 2021
  • +15 other locations
Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors

This study is to assess the safety and tolerability, and to assess the preliminary clinical benefit of NKTR-214 when combined with pembrolizumab (KEYTRUDA) with or without chemotherapy. The study is comprised of two groups; dose optimization and dose expansion cohorts. Dose Optimization will include first-line and second-line melanoma, non-small cell …

metastatic urothelial carcinoma
brain metastases
growth factor
Investigator Site- Fayetteville
 (7.8 away) Contact site
  • 02 Sep, 2021
  • +69 other locations
A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

This is a multicenter, open-label, Phase 1 study of ABBV-011 given as a single agent and in combination with budigalimab (ABBV-181) in participants with relapsed or refractory small cell lung cancer (SCLC). The study consists of 4 parts: Part A is a single-agent ABBV-011 dose regimen finding cohort; followed by …

cancer chemotherapy
renal function test
measurable disease
Highlands Oncology Group /ID# 207176
 (6.3 away) Contact site
  • 15 Sep, 2021
  • +39 other locations
A Safety Pharmacokinetic Pharmacodynamic and Anti-Tumor Study of PF-06873600 as a Single Agent and in Combination With Endocrine Therapy

Open-label, multi-center, non-randomized, multiple dose, safety, tolerability, pharmacokinetic, and pharmacodynamics and clinical activity study of PF-06873600 administered as a single agent and then in combination with endocrine therapy. The study contains two parts, a Part 1 single agent dose escalation and combination endocrine therapy dose finding component and a Part …

Highlands Oncology Group
 (1.2 away) Contact site
  • 15 Sep, 2021
  • +27 other locations